MX9202282A - Nuevos derivados de 3-amino piridazinas, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. - Google Patents

Nuevos derivados de 3-amino piridazinas, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.

Info

Publication number
MX9202282A
MX9202282A MX9202282A MX9202282A MX9202282A MX 9202282 A MX9202282 A MX 9202282A MX 9202282 A MX9202282 A MX 9202282A MX 9202282 A MX9202282 A MX 9202282A MX 9202282 A MX9202282 A MX 9202282A
Authority
MX
Mexico
Prior art keywords
image
piridazines
amino
procedure
contain
Prior art date
Application number
MX9202282A
Other languages
English (en)
Inventor
Jean-Jacques Bourguignon
Jean-Paul Kan
Camille George Wermuth
Original Assignee
Sanofi Elf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Elf filed Critical Sanofi Elf
Publication of MX9202282A publication Critical patent/MX9202282A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX9202282A 1991-05-16 1992-05-15 Nuevos derivados de 3-amino piridazinas, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. MX9202282A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9105973A FR2676444B1 (fr) 1991-05-16 1991-05-16 Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.

Publications (1)

Publication Number Publication Date
MX9202282A true MX9202282A (es) 1992-12-01

Family

ID=9412856

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9202282A MX9202282A (es) 1991-05-16 1992-05-15 Nuevos derivados de 3-amino piridazinas, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.

Country Status (23)

Country Link
US (1) US5276036A (es)
EP (1) EP0514277B1 (es)
JP (1) JPH0673021A (es)
KR (1) KR920021517A (es)
AT (1) ATE115569T1 (es)
AU (1) AU656770B2 (es)
BR (1) BR9201854A (es)
CA (1) CA2068770A1 (es)
CZ (1) CZ282531B6 (es)
DE (1) DE69200895T2 (es)
DK (1) DK0514277T3 (es)
ES (1) ES2065755T3 (es)
FI (1) FI922235A (es)
FR (1) FR2676444B1 (es)
GR (1) GR3015389T3 (es)
HU (2) HUT61305A (es)
IE (1) IE66926B1 (es)
IL (1) IL101885A (es)
MX (1) MX9202282A (es)
NO (1) NO180233C (es)
NZ (1) NZ242760A (es)
RU (1) RU2088577C1 (es)
TW (1) TW227997B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656631A (en) * 1989-02-07 1997-08-12 Sanofi Pyridazine derivatives
US5461053A (en) * 1989-02-07 1995-10-24 Sanofi Pyridazine derivatives
JP2983141B2 (ja) * 1993-10-06 1999-11-29 株式会社三和化学研究所 新規化合物及び該化合物を有効成分とする脳機能改善剤
GB9707693D0 (en) * 1997-04-16 1997-06-04 Smithkline Beecham Plc Novel method of treatment
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
ES2311126T3 (es) * 2000-05-26 2009-02-01 Pfizer Inc. Derivados de triazolil tropano como moduladores de ccr5.
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
US8265724B2 (en) * 2007-03-09 2012-09-11 Nellcor Puritan Bennett Llc Cancellation of light shunting
EP2560488B1 (en) 2010-04-23 2015-10-28 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
GB2579747B8 (en) 2017-08-04 2022-10-05 Skyhawk Therapeutics Inc Methods and compositions for modulating splicing
US11414406B2 (en) * 2018-02-02 2022-08-16 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor M4
WO2020163405A1 (en) 2019-02-05 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing
CN114007612A (zh) * 2019-02-05 2022-02-01 斯基霍克疗法公司 用于调节剪接的方法和组合物
KR20210123344A (ko) * 2019-02-05 2021-10-13 스카이호크 테라퓨틱스, 인코포레이티드 스플라이싱을 조절하는 방법 및 조성물
WO2020163406A1 (en) * 2019-02-05 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing
JP2022519323A (ja) 2019-02-06 2022-03-22 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
AR119731A1 (es) 2019-05-17 2022-01-05 Novartis Ag Inhibidores del inflamasoma nlrp3
US11129829B2 (en) 2019-06-17 2021-09-28 Skyhawk Therapeutics, Inc. Methods for modulating splicing
JP2024505735A (ja) * 2021-02-08 2024-02-07 メッドシャイン ディスカバリー インコーポレイテッド 置換されたピリダジンフェノール系誘導体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2539741A1 (fr) * 1983-01-21 1984-07-27 Sanofi Sa Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
FR2663326B2 (fr) * 1989-11-17 1992-10-16 Sanofi Sa Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
FR2642648B1 (fr) * 1989-02-07 1991-06-21 Sanofi Sa Utilisation de derives d'alkyl-5 pyridazine comme medicaments actifs sur le systeme cholinergique
PT93060B (pt) * 1989-02-07 1995-12-29 Sanofi Sa Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem
FR2665442B1 (fr) * 1990-07-31 1992-12-04 Sanofi Sa Derives d'alkyl-6 pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
GB8911158D0 (en) * 1989-05-16 1989-07-05 Janssen Pharmaceutica Nv Antiviral pyridazinamines

Also Published As

Publication number Publication date
NO921949L (no) 1992-11-17
TW227997B (es) 1994-08-11
DE69200895D1 (de) 1995-01-26
DK0514277T3 (da) 1995-05-01
FR2676444A1 (fr) 1992-11-20
CZ147392A3 (en) 1993-03-17
ES2065755T3 (es) 1995-02-16
NO180233B (no) 1996-12-02
EP0514277A1 (fr) 1992-11-19
IE921557A1 (en) 1992-11-18
FR2676444B1 (fr) 1995-03-10
IL101885A (en) 1996-08-04
HU9201626D0 (en) 1992-08-28
CZ282531B6 (cs) 1997-08-13
IE66926B1 (en) 1996-02-07
JPH0673021A (ja) 1994-03-15
DE69200895T2 (de) 1995-06-29
FI922235A0 (fi) 1992-05-15
RU2088577C1 (ru) 1997-08-27
EP0514277B1 (fr) 1994-12-14
HU211920A9 (en) 1996-01-29
CA2068770A1 (en) 1992-11-17
FI922235A (fi) 1992-11-17
BR9201854A (pt) 1993-01-05
IL101885A0 (en) 1992-12-30
ATE115569T1 (de) 1994-12-15
AU1627492A (en) 1992-11-19
GR3015389T3 (en) 1995-06-30
NZ242760A (en) 1994-12-22
KR920021517A (ko) 1992-12-18
AU656770B2 (en) 1995-02-16
NO180233C (no) 1997-03-12
US5276036A (en) 1994-01-04
HUT61305A (en) 1992-12-28
NO921949D0 (no) 1992-05-15

Similar Documents

Publication Publication Date Title
MX9202282A (es) Nuevos derivados de 3-amino piridazinas, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
PT97710A (pt) Processo para a preparacao de novos derivados da amino-piperidina,da amino-pirrolidina e de amino-per-hidroazepina
ES2084808T3 (es) Uso de un fosfato de un alfa-tocoferol, o de uno de sus derivados para la preparacion de composiciones cosmeticas, dermatologicas, o farmaceuticas; composiciones asi obtenidas.
ES2076009T3 (es) Nuevos inhibidores de n-miristoil-transferasa, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2118203T3 (es) Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
BR0110211A (pt) Derivados de oxadiazol tendo efeitos anticâncer
ES2191202T3 (es) Derivados de benzoilaminotiazol sustituidos y medicamentos que los contienen.
AR003137A1 (es) Una composicion farmaceutica para tratar la leucemia
MX9203360A (es) Derivados de hexahidroazepinas y composiciones farmaceuticas que los contienen.
ES2062870T3 (es) Nuevos derivados de acil-amino-fenol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
NO912298L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksanderivater.
DK661088A (da) N-(23-vinblastinoyl)derivater af 1-aminomethylphosphonsyre, fremgangsmaade til deres fremstilling og farmaceutiske midelr indeholdende dem
ES2069249T3 (es) Derivados de imidazol, su procedimiento de preparacion y los compuestos farmaceuticos que los contienen.
ES2118343T3 (es) Nuevos derivados de 2-(1h)-quinoleinona, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
MX9203929A (es) Derivados de 1,2,4-tiadiazino[3,4-b]benzotiazol, procedimiento para su preparacion y medicamentos que los contienen.
ES2065192T3 (es) Nuevos nicotinatos de diacil-glicerol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2118340T3 (es) Nuevos derivados de benzo-espiro-alquenos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2192827T3 (es) Derivados de 8h-(2,3-b)-pirrolicin-8-ona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2091670T3 (es) Nuevos derivados (ciclohexil)-alquenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2123038T3 (es) Nuevos derivados pirrolo-tieno-pirazinicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2099973T3 (es) Derivados de ureido-acetamida su preparacion y los medicamentos que los contienen.